Global Asthma Preventive Market Growth 2025-2031
The global Asthma Preventive market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Asthma Preventive Industry Forecast” looks at past sales and reviews total world Asthma Preventive sales in 2024, providing a comprehensive analysis by region and market sector of projected Asthma Preventive sales for 2025 through 2031. With Asthma Preventive sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Asthma Preventive industry.
This Insight Report provides a comprehensive analysis of the global Asthma Preventive landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Asthma Preventive portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Asthma Preventive market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Asthma Preventive and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Asthma Preventive.
This report presents a comprehensive overview, market shares, and growth opportunities of Asthma Preventive market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Asthma Preventive market?
What factors are driving Asthma Preventive market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Asthma Preventive market opportunities vary by end market size?
How does Asthma Preventive break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Asthma Preventive Industry Forecast” looks at past sales and reviews total world Asthma Preventive sales in 2024, providing a comprehensive analysis by region and market sector of projected Asthma Preventive sales for 2025 through 2031. With Asthma Preventive sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Asthma Preventive industry.
This Insight Report provides a comprehensive analysis of the global Asthma Preventive landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Asthma Preventive portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Asthma Preventive market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Asthma Preventive and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Asthma Preventive.
This report presents a comprehensive overview, market shares, and growth opportunities of Asthma Preventive market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Sodium Cromolyn
- Prednisolone
- Children
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Abbot
- Novartis
- Roche
- GSK
- Merck
- Astrazeneca
- Biotest AG
- Boehringer Ingelheim
- Chiesi
- Sumitomo Dainippon Pharma
- Amgen
What is the 10-year outlook for the global Asthma Preventive market?
What factors are driving Asthma Preventive market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Asthma Preventive market opportunities vary by end market size?
How does Asthma Preventive break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Asthma Preventive Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Asthma Preventive by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Asthma Preventive by Country/Region, 2020, 2024 & 2031
2.2 Asthma Preventive Segment by Type
2.2.1 Sodium Cromolyn
2.2.2 Prednisolone
2.3 Asthma Preventive Sales by Type
2.3.1 Global Asthma Preventive Sales Market Share by Type (2020-2025)
2.3.2 Global Asthma Preventive Revenue and Market Share by Type (2020-2025)
2.3.3 Global Asthma Preventive Sale Price by Type (2020-2025)
2.4 Asthma Preventive Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Asthma Preventive Sales by Application
2.5.1 Global Asthma Preventive Sale Market Share by Application (2020-2025)
2.5.2 Global Asthma Preventive Revenue and Market Share by Application (2020-2025)
2.5.3 Global Asthma Preventive Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Asthma Preventive Breakdown Data by Company
3.1.1 Global Asthma Preventive Annual Sales by Company (2020-2025)
3.1.2 Global Asthma Preventive Sales Market Share by Company (2020-2025)
3.2 Global Asthma Preventive Annual Revenue by Company (2020-2025)
3.2.1 Global Asthma Preventive Revenue by Company (2020-2025)
3.2.2 Global Asthma Preventive Revenue Market Share by Company (2020-2025)
3.3 Global Asthma Preventive Sale Price by Company
3.4 Key Manufacturers Asthma Preventive Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Asthma Preventive Product Location Distribution
3.4.2 Players Asthma Preventive Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ASTHMA PREVENTIVE BY GEOGRAPHIC REGION
4.1 World Historic Asthma Preventive Market Size by Geographic Region (2020-2025)
4.1.1 Global Asthma Preventive Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Asthma Preventive Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Asthma Preventive Market Size by Country/Region (2020-2025)
4.2.1 Global Asthma Preventive Annual Sales by Country/Region (2020-2025)
4.2.2 Global Asthma Preventive Annual Revenue by Country/Region (2020-2025)
4.3 Americas Asthma Preventive Sales Growth
4.4 APAC Asthma Preventive Sales Growth
4.5 Europe Asthma Preventive Sales Growth
4.6 Middle East & Africa Asthma Preventive Sales Growth
5 AMERICAS
5.1 Americas Asthma Preventive Sales by Country
5.1.1 Americas Asthma Preventive Sales by Country (2020-2025)
5.1.2 Americas Asthma Preventive Revenue by Country (2020-2025)
5.2 Americas Asthma Preventive Sales by Type (2020-2025)
5.3 Americas Asthma Preventive Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Preventive Sales by Region
6.1.1 APAC Asthma Preventive Sales by Region (2020-2025)
6.1.2 APAC Asthma Preventive Revenue by Region (2020-2025)
6.2 APAC Asthma Preventive Sales by Type (2020-2025)
6.3 APAC Asthma Preventive Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Asthma Preventive by Country
7.1.1 Europe Asthma Preventive Sales by Country (2020-2025)
7.1.2 Europe Asthma Preventive Revenue by Country (2020-2025)
7.2 Europe Asthma Preventive Sales by Type (2020-2025)
7.3 Europe Asthma Preventive Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Asthma Preventive by Country
8.1.1 Middle East & Africa Asthma Preventive Sales by Country (2020-2025)
8.1.2 Middle East & Africa Asthma Preventive Revenue by Country (2020-2025)
8.2 Middle East & Africa Asthma Preventive Sales by Type (2020-2025)
8.3 Middle East & Africa Asthma Preventive Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Asthma Preventive
10.3 Manufacturing Process Analysis of Asthma Preventive
10.4 Industry Chain Structure of Asthma Preventive
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Asthma Preventive Distributors
11.3 Asthma Preventive Customer
12 WORLD FORECAST REVIEW FOR ASTHMA PREVENTIVE BY GEOGRAPHIC REGION
12.1 Global Asthma Preventive Market Size Forecast by Region
12.1.1 Global Asthma Preventive Forecast by Region (2026-2031)
12.1.2 Global Asthma Preventive Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Asthma Preventive Forecast by Type (2026-2031)
12.7 Global Asthma Preventive Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Asthma Preventive Product Portfolios and Specifications
13.1.3 Pfizer Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Abbot
13.2.1 Abbot Company Information
13.2.2 Abbot Asthma Preventive Product Portfolios and Specifications
13.2.3 Abbot Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Abbot Main Business Overview
13.2.5 Abbot Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Asthma Preventive Product Portfolios and Specifications
13.3.3 Novartis Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Asthma Preventive Product Portfolios and Specifications
13.4.3 Roche Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Asthma Preventive Product Portfolios and Specifications
13.5.3 GSK Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Asthma Preventive Product Portfolios and Specifications
13.6.3 Merck Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Astrazeneca
13.7.1 Astrazeneca Company Information
13.7.2 Astrazeneca Asthma Preventive Product Portfolios and Specifications
13.7.3 Astrazeneca Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Astrazeneca Main Business Overview
13.7.5 Astrazeneca Latest Developments
13.8 Biotest AG
13.8.1 Biotest AG Company Information
13.8.2 Biotest AG Asthma Preventive Product Portfolios and Specifications
13.8.3 Biotest AG Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biotest AG Main Business Overview
13.8.5 Biotest AG Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Asthma Preventive Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Chiesi
13.10.1 Chiesi Company Information
13.10.2 Chiesi Asthma Preventive Product Portfolios and Specifications
13.10.3 Chiesi Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Chiesi Main Business Overview
13.10.5 Chiesi Latest Developments
13.11 Sumitomo Dainippon Pharma
13.11.1 Sumitomo Dainippon Pharma Company Information
13.11.2 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolios and Specifications
13.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sumitomo Dainippon Pharma Main Business Overview
13.11.5 Sumitomo Dainippon Pharma Latest Developments
13.12 Amgen
13.12.1 Amgen Company Information
13.12.2 Amgen Asthma Preventive Product Portfolios and Specifications
13.12.3 Amgen Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Amgen Main Business Overview
13.12.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Asthma Preventive Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Asthma Preventive by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Asthma Preventive by Country/Region, 2020, 2024 & 2031
2.2 Asthma Preventive Segment by Type
2.2.1 Sodium Cromolyn
2.2.2 Prednisolone
2.3 Asthma Preventive Sales by Type
2.3.1 Global Asthma Preventive Sales Market Share by Type (2020-2025)
2.3.2 Global Asthma Preventive Revenue and Market Share by Type (2020-2025)
2.3.3 Global Asthma Preventive Sale Price by Type (2020-2025)
2.4 Asthma Preventive Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Asthma Preventive Sales by Application
2.5.1 Global Asthma Preventive Sale Market Share by Application (2020-2025)
2.5.2 Global Asthma Preventive Revenue and Market Share by Application (2020-2025)
2.5.3 Global Asthma Preventive Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Asthma Preventive Breakdown Data by Company
3.1.1 Global Asthma Preventive Annual Sales by Company (2020-2025)
3.1.2 Global Asthma Preventive Sales Market Share by Company (2020-2025)
3.2 Global Asthma Preventive Annual Revenue by Company (2020-2025)
3.2.1 Global Asthma Preventive Revenue by Company (2020-2025)
3.2.2 Global Asthma Preventive Revenue Market Share by Company (2020-2025)
3.3 Global Asthma Preventive Sale Price by Company
3.4 Key Manufacturers Asthma Preventive Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Asthma Preventive Product Location Distribution
3.4.2 Players Asthma Preventive Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ASTHMA PREVENTIVE BY GEOGRAPHIC REGION
4.1 World Historic Asthma Preventive Market Size by Geographic Region (2020-2025)
4.1.1 Global Asthma Preventive Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Asthma Preventive Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Asthma Preventive Market Size by Country/Region (2020-2025)
4.2.1 Global Asthma Preventive Annual Sales by Country/Region (2020-2025)
4.2.2 Global Asthma Preventive Annual Revenue by Country/Region (2020-2025)
4.3 Americas Asthma Preventive Sales Growth
4.4 APAC Asthma Preventive Sales Growth
4.5 Europe Asthma Preventive Sales Growth
4.6 Middle East & Africa Asthma Preventive Sales Growth
5 AMERICAS
5.1 Americas Asthma Preventive Sales by Country
5.1.1 Americas Asthma Preventive Sales by Country (2020-2025)
5.1.2 Americas Asthma Preventive Revenue by Country (2020-2025)
5.2 Americas Asthma Preventive Sales by Type (2020-2025)
5.3 Americas Asthma Preventive Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Preventive Sales by Region
6.1.1 APAC Asthma Preventive Sales by Region (2020-2025)
6.1.2 APAC Asthma Preventive Revenue by Region (2020-2025)
6.2 APAC Asthma Preventive Sales by Type (2020-2025)
6.3 APAC Asthma Preventive Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Asthma Preventive by Country
7.1.1 Europe Asthma Preventive Sales by Country (2020-2025)
7.1.2 Europe Asthma Preventive Revenue by Country (2020-2025)
7.2 Europe Asthma Preventive Sales by Type (2020-2025)
7.3 Europe Asthma Preventive Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Asthma Preventive by Country
8.1.1 Middle East & Africa Asthma Preventive Sales by Country (2020-2025)
8.1.2 Middle East & Africa Asthma Preventive Revenue by Country (2020-2025)
8.2 Middle East & Africa Asthma Preventive Sales by Type (2020-2025)
8.3 Middle East & Africa Asthma Preventive Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Asthma Preventive
10.3 Manufacturing Process Analysis of Asthma Preventive
10.4 Industry Chain Structure of Asthma Preventive
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Asthma Preventive Distributors
11.3 Asthma Preventive Customer
12 WORLD FORECAST REVIEW FOR ASTHMA PREVENTIVE BY GEOGRAPHIC REGION
12.1 Global Asthma Preventive Market Size Forecast by Region
12.1.1 Global Asthma Preventive Forecast by Region (2026-2031)
12.1.2 Global Asthma Preventive Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Asthma Preventive Forecast by Type (2026-2031)
12.7 Global Asthma Preventive Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Asthma Preventive Product Portfolios and Specifications
13.1.3 Pfizer Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Abbot
13.2.1 Abbot Company Information
13.2.2 Abbot Asthma Preventive Product Portfolios and Specifications
13.2.3 Abbot Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Abbot Main Business Overview
13.2.5 Abbot Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Asthma Preventive Product Portfolios and Specifications
13.3.3 Novartis Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Asthma Preventive Product Portfolios and Specifications
13.4.3 Roche Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Asthma Preventive Product Portfolios and Specifications
13.5.3 GSK Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Asthma Preventive Product Portfolios and Specifications
13.6.3 Merck Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Astrazeneca
13.7.1 Astrazeneca Company Information
13.7.2 Astrazeneca Asthma Preventive Product Portfolios and Specifications
13.7.3 Astrazeneca Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Astrazeneca Main Business Overview
13.7.5 Astrazeneca Latest Developments
13.8 Biotest AG
13.8.1 Biotest AG Company Information
13.8.2 Biotest AG Asthma Preventive Product Portfolios and Specifications
13.8.3 Biotest AG Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biotest AG Main Business Overview
13.8.5 Biotest AG Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Asthma Preventive Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Chiesi
13.10.1 Chiesi Company Information
13.10.2 Chiesi Asthma Preventive Product Portfolios and Specifications
13.10.3 Chiesi Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Chiesi Main Business Overview
13.10.5 Chiesi Latest Developments
13.11 Sumitomo Dainippon Pharma
13.11.1 Sumitomo Dainippon Pharma Company Information
13.11.2 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolios and Specifications
13.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sumitomo Dainippon Pharma Main Business Overview
13.11.5 Sumitomo Dainippon Pharma Latest Developments
13.12 Amgen
13.12.1 Amgen Company Information
13.12.2 Amgen Asthma Preventive Product Portfolios and Specifications
13.12.3 Amgen Asthma Preventive Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Amgen Main Business Overview
13.12.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Asthma Preventive Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Asthma Preventive Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sodium Cromolyn
Table 4. Major Players of Prednisolone
Table 5. Global Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 6. Global Asthma Preventive Sales Market Share by Type (2020-2025)
Table 7. Global Asthma Preventive Revenue by Type (2020-2025) & ($ million)
Table 8. Global Asthma Preventive Revenue Market Share by Type (2020-2025)
Table 9. Global Asthma Preventive Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Asthma Preventive Sale by Application (2020-2025) & (K Units)
Table 11. Global Asthma Preventive Sale Market Share by Application (2020-2025)
Table 12. Global Asthma Preventive Revenue by Application (2020-2025) & ($ million)
Table 13. Global Asthma Preventive Revenue Market Share by Application (2020-2025)
Table 14. Global Asthma Preventive Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Asthma Preventive Sales by Company (2020-2025) & (K Units)
Table 16. Global Asthma Preventive Sales Market Share by Company (2020-2025)
Table 17. Global Asthma Preventive Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Asthma Preventive Revenue Market Share by Company (2020-2025)
Table 19. Global Asthma Preventive Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Asthma Preventive Producing Area Distribution and Sales Area
Table 21. Players Asthma Preventive Products Offered
Table 22. Asthma Preventive Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Asthma Preventive Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Asthma Preventive Sales Market Share Geographic Region (2020-2025)
Table 27. Global Asthma Preventive Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Asthma Preventive Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Asthma Preventive Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Asthma Preventive Sales Market Share by Country/Region (2020-2025)
Table 31. Global Asthma Preventive Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Asthma Preventive Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Asthma Preventive Sales by Country (2020-2025) & (K Units)
Table 34. Americas Asthma Preventive Sales Market Share by Country (2020-2025)
Table 35. Americas Asthma Preventive Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 37. Americas Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 38. APAC Asthma Preventive Sales by Region (2020-2025) & (K Units)
Table 39. APAC Asthma Preventive Sales Market Share by Region (2020-2025)
Table 40. APAC Asthma Preventive Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 42. APAC Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 43. Europe Asthma Preventive Sales by Country (2020-2025) & (K Units)
Table 44. Europe Asthma Preventive Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 46. Europe Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Asthma Preventive Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Asthma Preventive Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Asthma Preventive
Table 52. Key Market Challenges & Risks of Asthma Preventive
Table 53. Key Industry Trends of Asthma Preventive
Table 54. Asthma Preventive Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Asthma Preventive Distributors List
Table 57. Asthma Preventive Customer List
Table 58. Global Asthma Preventive Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Asthma Preventive Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Asthma Preventive Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Asthma Preventive Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Asthma Preventive Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Asthma Preventive Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Asthma Preventive Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Asthma Preventive Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Asthma Preventive Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Asthma Preventive Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Asthma Preventive Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Asthma Preventive Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Asthma Preventive Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Asthma Preventive Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Asthma Preventive Product Portfolios and Specifications
Table 74. Pfizer Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Abbot Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 78. Abbot Asthma Preventive Product Portfolios and Specifications
Table 79. Abbot Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Abbot Main Business
Table 81. Abbot Latest Developments
Table 82. Novartis Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis Asthma Preventive Product Portfolios and Specifications
Table 84. Novartis Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Roche Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Asthma Preventive Product Portfolios and Specifications
Table 89. Roche Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. GSK Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Asthma Preventive Product Portfolios and Specifications
Table 94. GSK Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Asthma Preventive Product Portfolios and Specifications
Table 99. Merck Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Astrazeneca Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 103. Astrazeneca Asthma Preventive Product Portfolios and Specifications
Table 104. Astrazeneca Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Astrazeneca Main Business
Table 106. Astrazeneca Latest Developments
Table 107. Biotest AG Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 108. Biotest AG Asthma Preventive Product Portfolios and Specifications
Table 109. Biotest AG Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Biotest AG Main Business
Table 111. Biotest AG Latest Developments
Table 112. Boehringer Ingelheim Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 113. Boehringer Ingelheim Asthma Preventive Product Portfolios and Specifications
Table 114. Boehringer Ingelheim Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Boehringer Ingelheim Main Business
Table 116. Boehringer Ingelheim Latest Developments
Table 117. Chiesi Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 118. Chiesi Asthma Preventive Product Portfolios and Specifications
Table 119. Chiesi Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Chiesi Main Business
Table 121. Chiesi Latest Developments
Table 122. Sumitomo Dainippon Pharma Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 123. Sumitomo Dainippon Pharma Asthma Preventive Product Portfolios and Specifications
Table 124. Sumitomo Dainippon Pharma Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Sumitomo Dainippon Pharma Main Business
Table 126. Sumitomo Dainippon Pharma Latest Developments
Table 127. Amgen Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 128. Amgen Asthma Preventive Product Portfolios and Specifications
Table 129. Amgen Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Amgen Main Business
Table 131. Amgen Latest Developments
Table 1. Asthma Preventive Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Asthma Preventive Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sodium Cromolyn
Table 4. Major Players of Prednisolone
Table 5. Global Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 6. Global Asthma Preventive Sales Market Share by Type (2020-2025)
Table 7. Global Asthma Preventive Revenue by Type (2020-2025) & ($ million)
Table 8. Global Asthma Preventive Revenue Market Share by Type (2020-2025)
Table 9. Global Asthma Preventive Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Asthma Preventive Sale by Application (2020-2025) & (K Units)
Table 11. Global Asthma Preventive Sale Market Share by Application (2020-2025)
Table 12. Global Asthma Preventive Revenue by Application (2020-2025) & ($ million)
Table 13. Global Asthma Preventive Revenue Market Share by Application (2020-2025)
Table 14. Global Asthma Preventive Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Asthma Preventive Sales by Company (2020-2025) & (K Units)
Table 16. Global Asthma Preventive Sales Market Share by Company (2020-2025)
Table 17. Global Asthma Preventive Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Asthma Preventive Revenue Market Share by Company (2020-2025)
Table 19. Global Asthma Preventive Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Asthma Preventive Producing Area Distribution and Sales Area
Table 21. Players Asthma Preventive Products Offered
Table 22. Asthma Preventive Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Asthma Preventive Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Asthma Preventive Sales Market Share Geographic Region (2020-2025)
Table 27. Global Asthma Preventive Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Asthma Preventive Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Asthma Preventive Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Asthma Preventive Sales Market Share by Country/Region (2020-2025)
Table 31. Global Asthma Preventive Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Asthma Preventive Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Asthma Preventive Sales by Country (2020-2025) & (K Units)
Table 34. Americas Asthma Preventive Sales Market Share by Country (2020-2025)
Table 35. Americas Asthma Preventive Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 37. Americas Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 38. APAC Asthma Preventive Sales by Region (2020-2025) & (K Units)
Table 39. APAC Asthma Preventive Sales Market Share by Region (2020-2025)
Table 40. APAC Asthma Preventive Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 42. APAC Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 43. Europe Asthma Preventive Sales by Country (2020-2025) & (K Units)
Table 44. Europe Asthma Preventive Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 46. Europe Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Asthma Preventive Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Asthma Preventive Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Asthma Preventive Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Asthma Preventive Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Asthma Preventive
Table 52. Key Market Challenges & Risks of Asthma Preventive
Table 53. Key Industry Trends of Asthma Preventive
Table 54. Asthma Preventive Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Asthma Preventive Distributors List
Table 57. Asthma Preventive Customer List
Table 58. Global Asthma Preventive Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Asthma Preventive Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Asthma Preventive Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Asthma Preventive Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Asthma Preventive Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Asthma Preventive Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Asthma Preventive Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Asthma Preventive Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Asthma Preventive Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Asthma Preventive Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Asthma Preventive Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Asthma Preventive Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Asthma Preventive Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Asthma Preventive Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Asthma Preventive Product Portfolios and Specifications
Table 74. Pfizer Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Abbot Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 78. Abbot Asthma Preventive Product Portfolios and Specifications
Table 79. Abbot Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Abbot Main Business
Table 81. Abbot Latest Developments
Table 82. Novartis Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis Asthma Preventive Product Portfolios and Specifications
Table 84. Novartis Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Roche Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Asthma Preventive Product Portfolios and Specifications
Table 89. Roche Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. GSK Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Asthma Preventive Product Portfolios and Specifications
Table 94. GSK Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Asthma Preventive Product Portfolios and Specifications
Table 99. Merck Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Astrazeneca Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 103. Astrazeneca Asthma Preventive Product Portfolios and Specifications
Table 104. Astrazeneca Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Astrazeneca Main Business
Table 106. Astrazeneca Latest Developments
Table 107. Biotest AG Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 108. Biotest AG Asthma Preventive Product Portfolios and Specifications
Table 109. Biotest AG Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Biotest AG Main Business
Table 111. Biotest AG Latest Developments
Table 112. Boehringer Ingelheim Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 113. Boehringer Ingelheim Asthma Preventive Product Portfolios and Specifications
Table 114. Boehringer Ingelheim Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Boehringer Ingelheim Main Business
Table 116. Boehringer Ingelheim Latest Developments
Table 117. Chiesi Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 118. Chiesi Asthma Preventive Product Portfolios and Specifications
Table 119. Chiesi Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Chiesi Main Business
Table 121. Chiesi Latest Developments
Table 122. Sumitomo Dainippon Pharma Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 123. Sumitomo Dainippon Pharma Asthma Preventive Product Portfolios and Specifications
Table 124. Sumitomo Dainippon Pharma Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Sumitomo Dainippon Pharma Main Business
Table 126. Sumitomo Dainippon Pharma Latest Developments
Table 127. Amgen Basic Information, Asthma Preventive Manufacturing Base, Sales Area and Its Competitors
Table 128. Amgen Asthma Preventive Product Portfolios and Specifications
Table 129. Amgen Asthma Preventive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Amgen Main Business
Table 131. Amgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Asthma Preventive
Figure 2. Asthma Preventive Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Asthma Preventive Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Asthma Preventive Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Asthma Preventive Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Asthma Preventive Sales Market Share by Country/Region (2024)
Figure 10. Asthma Preventive Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sodium Cromolyn
Figure 12. Product Picture of Prednisolone
Figure 13. Global Asthma Preventive Sales Market Share by Type in 2025
Figure 14. Global Asthma Preventive Revenue Market Share by Type (2020-2025)
Figure 15. Asthma Preventive Consumed in Children
Figure 16. Global Asthma Preventive Market: Children (2020-2025) & (K Units)
Figure 17. Asthma Preventive Consumed in Adult
Figure 18. Global Asthma Preventive Market: Adult (2020-2025) & (K Units)
Figure 19. Global Asthma Preventive Sale Market Share by Application (2024)
Figure 20. Global Asthma Preventive Revenue Market Share by Application in 2025
Figure 21. Asthma Preventive Sales by Company in 2025 (K Units)
Figure 22. Global Asthma Preventive Sales Market Share by Company in 2025
Figure 23. Asthma Preventive Revenue by Company in 2025 ($ millions)
Figure 24. Global Asthma Preventive Revenue Market Share by Company in 2025
Figure 25. Global Asthma Preventive Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Asthma Preventive Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Asthma Preventive Sales 2020-2025 (K Units)
Figure 28. Americas Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 29. APAC Asthma Preventive Sales 2020-2025 (K Units)
Figure 30. APAC Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 31. Europe Asthma Preventive Sales 2020-2025 (K Units)
Figure 32. Europe Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Asthma Preventive Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 35. Americas Asthma Preventive Sales Market Share by Country in 2025
Figure 36. Americas Asthma Preventive Revenue Market Share by Country (2020-2025)
Figure 37. Americas Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 38. Americas Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 39. United States Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Asthma Preventive Sales Market Share by Region in 2025
Figure 44. APAC Asthma Preventive Revenue Market Share by Region (2020-2025)
Figure 45. APAC Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 46. APAC Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 47. China Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 51. India Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Asthma Preventive Sales Market Share by Country in 2025
Figure 55. Europe Asthma Preventive Revenue Market Share by Country (2020-2025)
Figure 56. Europe Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 57. Europe Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 58. Germany Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 59. France Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Asthma Preventive Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 66. Egypt Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Asthma Preventive in 2025
Figure 72. Manufacturing Process Analysis of Asthma Preventive
Figure 73. Industry Chain Structure of Asthma Preventive
Figure 74. Channels of Distribution
Figure 75. Global Asthma Preventive Sales Market Forecast by Region (2026-2031)
Figure 76. Global Asthma Preventive Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Asthma Preventive Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Asthma Preventive Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Asthma Preventive Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Asthma Preventive Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Asthma Preventive
Figure 2. Asthma Preventive Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Asthma Preventive Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Asthma Preventive Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Asthma Preventive Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Asthma Preventive Sales Market Share by Country/Region (2024)
Figure 10. Asthma Preventive Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sodium Cromolyn
Figure 12. Product Picture of Prednisolone
Figure 13. Global Asthma Preventive Sales Market Share by Type in 2025
Figure 14. Global Asthma Preventive Revenue Market Share by Type (2020-2025)
Figure 15. Asthma Preventive Consumed in Children
Figure 16. Global Asthma Preventive Market: Children (2020-2025) & (K Units)
Figure 17. Asthma Preventive Consumed in Adult
Figure 18. Global Asthma Preventive Market: Adult (2020-2025) & (K Units)
Figure 19. Global Asthma Preventive Sale Market Share by Application (2024)
Figure 20. Global Asthma Preventive Revenue Market Share by Application in 2025
Figure 21. Asthma Preventive Sales by Company in 2025 (K Units)
Figure 22. Global Asthma Preventive Sales Market Share by Company in 2025
Figure 23. Asthma Preventive Revenue by Company in 2025 ($ millions)
Figure 24. Global Asthma Preventive Revenue Market Share by Company in 2025
Figure 25. Global Asthma Preventive Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Asthma Preventive Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Asthma Preventive Sales 2020-2025 (K Units)
Figure 28. Americas Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 29. APAC Asthma Preventive Sales 2020-2025 (K Units)
Figure 30. APAC Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 31. Europe Asthma Preventive Sales 2020-2025 (K Units)
Figure 32. Europe Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Asthma Preventive Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Asthma Preventive Revenue 2020-2025 ($ millions)
Figure 35. Americas Asthma Preventive Sales Market Share by Country in 2025
Figure 36. Americas Asthma Preventive Revenue Market Share by Country (2020-2025)
Figure 37. Americas Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 38. Americas Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 39. United States Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Asthma Preventive Sales Market Share by Region in 2025
Figure 44. APAC Asthma Preventive Revenue Market Share by Region (2020-2025)
Figure 45. APAC Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 46. APAC Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 47. China Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 51. India Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Asthma Preventive Sales Market Share by Country in 2025
Figure 55. Europe Asthma Preventive Revenue Market Share by Country (2020-2025)
Figure 56. Europe Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 57. Europe Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 58. Germany Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 59. France Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Asthma Preventive Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Asthma Preventive Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Asthma Preventive Sales Market Share by Application (2020-2025)
Figure 66. Egypt Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Asthma Preventive Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Asthma Preventive in 2025
Figure 72. Manufacturing Process Analysis of Asthma Preventive
Figure 73. Industry Chain Structure of Asthma Preventive
Figure 74. Channels of Distribution
Figure 75. Global Asthma Preventive Sales Market Forecast by Region (2026-2031)
Figure 76. Global Asthma Preventive Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Asthma Preventive Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Asthma Preventive Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Asthma Preventive Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Asthma Preventive Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Asthma and COPD Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
June 2024
97 pages
